Insight

Kimryn Rathmell: Honoring Dr. Rosenberg and discussing the past, present, and future of cellular immunotherapy

Collage Photo of Kimryn Rathmell and Steven Rosenberg

Aug 24, 2024, 05:58

Kimryn Rathmell: Honoring Dr. Rosenberg and discussing the past, present, and future of cellular immunotherapy

Kimryn Rathmell shared on X:

“In September, we’re celebrating Dr. Steven Rosenberg’s 50 years at NCI! A remarkable milestone in an extraordinary career.

Join us in honoring Dr. Rosenberg and discussing the past, present, and future of cellular immunotherapy.”

Kimryn Rathmell

Read Further.
Source: Kimryn Rathmell/X

For more posts by Kimryn Rathmell, visit oncodaily.com

Dr. Kimryn Rathmell is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers.

She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.

Currently serving as the director of the National Cancer Institute, Dr. Rathmell continues to lead research initiatives and advance the understanding and treatment of kidney cancer, ultimately improving the lives of patients worldwide.

Steven A. Rosenberg is an American cancer researcher and surgeon, serving as Chief of Surgery at the National Cancer Institute and Professor of Surgery at both the Uniformed Services University of Health Sciences and George Washington University. He pioneered effective immunotherapies and gene therapy, becoming the first to successfully insert foreign genes into humans.